Drugs Containing Carbohydrates and Derived Products 161
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Traditional Medicine
MINISTRY OF HEALTH DEPARTMENT OF MEDICAL RESEARCH (LOWER MYANMAR) -4 rf,"d .1, l,.ifr M '\t $.,iJ+j AI{I{OTATED BIBLIOGRAPHY OF TRADITIOI{AL MEDTCII\E RESEARCH CARRTED OUT AT DMR (LM) nURIf{G 196s-2011 f# #a# €€# 6rdffi t u 6 l6'6 ktibilicetidiT \ &, ft Ministry of Health Department of Medical Research (Lower Myanmar) Central Biomedical Library ANNOTATED BIBLIOGRAPHY OF TRADITIONAL MEDICINE RESEARCH CARRIED OUT AT DMR (LM) DURING 1965-2011 Compiled by Cho Mar Oo BA (Economics); DipLibSc Librarian, Central Biomedical Library Staff of Central Biomedical Library May Aye Than MBBS, MMedSc (Pharmacology) Deputy Director & Head Pharmacology Research Division Staff of Pharmacology Research Division Aung Myo Min BSc (Physics); DipLibSc; RL Librarian & Head (Retd.) Central Biomedical Library Ye Htut MBBS, MSc (Medical Parasitology) (London) DLSHTM, FRCP (Edin) Deputy Director-General Myo Khin MBBS, MD (New South Wales), DCH, FRCP (Edin) Acting Director General PREFACE Throughout recorded history, people of various cultures have relied on traditional medicine. Worldwide, only an estimated ten to thirty percent of human health care is delivered by conventional, biomedically oriented practitioners. The remaining seventy to ninety percent ranges from self-care according to folk principles, to care given in an organized health care system based on traditional medicine. Likewise, in Myanmar health care system, the existence of traditional medicine along with allopathic medicines is well recognized. Myanmar traditional medicine dates back 2,000 years and is well accepted and widely used by the people throughout history. Burma Medical Research Institute since it was established in 1963 had started a program of research on traditional medicinal plants including laboratory screening tests on animal models of herbs with reputed pharmacological properties-such as anti-dysentery, bronchodilator, hypoglycemic effects. -
Use of Substituted Cinnamic Acid Polymers to Treat AIDS
Europaisches Patentamt European Patent Office © Publication number: 0 544 321 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION © Application number: 92120293.3 mt . ci .5 :A61K 31/78 @ Date of filing: 27.11.92 ® Priority: 27.11.91 JP 337796/91 © Inventor: Konno, Kunio 1-33-3, Kakinokizaka, Meguro-ku © Date of publication of application: Tokyo(JP) 02.06.93 Bulletin 93/22 Inventor: Sakagami, Hiroshi Chigusadai Danchi 246, 33, Chigusadai, @ Designated Contracting States: Midori-ku CH DE FR GB IT LI NL SE Yokohama-shi, Kanagawa-ken(JP) Inventor: Kawazoe, Yutaka © Applicant: Konno, Kunio 5-14-14, Shimomeguro, Meguro-ku 1-33-3, Kakinokizaka, Meguro-ku Tokyo(JP) Tokyo(JP) Inventor: Yamamoto, Naoki Applicant: Sakagami, Hiroshi Haramachi Jutaka 501, 3-11, Ebisu Minami, Chigusadai Danchi 246, 33, Chigusadai, Midori-ku Shibuya-ku Yokohama-shi, Kanagawa-ken(JP) Tokyo(JP) Applicant: Kawazoe, Yutaka 5-14-14, Shimomeguro, Meguro-ku Tokyo(JP) 0 Representative: Hansen, Bernd, Dr.rer.nat. et Applicant: Yamamoto, Naoki al Haramachi Jutaka 501, 3-11, Ebisu Minami, Hoffmann, Eitle & Partner Patentanwalte Shibuya-ku Arabellastrasse 4 Postfach 81 04 20 Tokyo(JP) W-8000 Munchen 81 (DE) © Use of substituted cinnamic acid polymers to treat AIDS. © AIDS therapeutic agents are provided which are less toxic, have a strong anti-AIDS virus activity and comprise as an effective ingredient a dehydrogenation polymer of a cinnamic acid derivative having a phenyl group substituted with at least one hydroxyl group or a pharmaceutically acceptable salt thereof. CM 00 Rank Xerox (UK) Business Services (3. 10/3.6/3.3. 1) EP 0 544 321 A1 BACKGROUND OF THE INVENTION Field of the Invention 5 The present invention relates to AIDS therapeutic agents containing a dehydrogenation polymer of a substituted cinnamic acid as an effective ingredient. -
In Chemistry, Glycosides Are Certain Molecules in Which a Sugar Part Is
GLYCOSIDES Glycosides may be defined as the organic compounds from plants or animal sources, which on enzymatic or acid hydrolysis give one or more sugar moieties along with non- sugar moiety. Glycosides play numerous important roles in living organisms. Many plants store important chemicals in the form of inactive glycosides; if these chemicals are needed, the glycosides are brought in contact with water and an enzyme, and the sugar part is broken off, making the chemical available for use. Many such plant glycosides are used as medications. In animals (including humans), poisons are often bound to sugar molecules in order to remove them from the body. Formally, a glycoside is any molecule in which a sugar group is bonded through its carbon atom to another group via an O-glycosidic bond or an S-glycosidic bond; glycosides involving the latter are also called thioglycosides. The sugar group is then known as the glycone and the non-sugar group as the aglycone or genin part of the glycoside. The glycone can consist of a single sugar group (monosaccharide) or several sugar groups (oligosaccharide). Classification Classification based on linkages Based on the linkage of sugar moiety to aglycone part 1. O-Glycoside:-Here the sugar is combined with alcoholic or phenolic hydroxyl function of aglycone.eg:-digitalis. 2. N-glycosides:-Here nitrogen of amino group is condensed with a sugar ,eg- Nucleoside 3. S-glycoside:-Here sugar is combined with sulphur of aglycone,eg- isothiocyanate glycosides. 4. C-glycosides:-By condensation of a sugar with a cabon atom, eg-Cascaroside, aloin. Glycosides can be classified by the glycone, by the type of glycosidic bond, and by the aglycone. -
Decolorization of Glycosides
Europaisches Patentamt 0 338 151 European Patent Office v\) Publication number: A1 Office europeen des brevets EUROPEAN PATENT APPLICATION © Application number: 88303525.5 © int. Ci.4: C07H 15/04 @ Date of filing: 19.04.88 © Date of publication of application: © Applicant: HENKEL CORPORATION 25.10.89 Bulletin 89/43 300 Brookside Avenue Ambler Pennsylvania 19002(US) © Designated Contracting States: AT BE CH DE ES FR GB GR IT LI LU NL SE @ Inventor: McDaniel, Robert S., Jr. 968 Montgomery Court Oecatur Illinois 62526(US) Inventor: McCurry, Patrick M. 3146 Lake Bluff Drive Decatur Illinois 62521 (US) Inventor: Short, Rolland W.P. 2657 Gregory Court Decatur Illinois 62526(US) Inventor: Glor, Paul R. 448 Ewing Avenue Decatur Illinois 62522(US) ©" Representative: Harle, Horst, Dr. et al c/o Henkel KGaA TFP/Patentabteilung Postfach 1100 Henkelstrasse 67 D-4000 Dusseldorf(DE) © Decolorization of glycosides. © Hydrogenation of a glycoside composition is ef- fected to reduce the color of the composition. < in CO Xerox Copy Centre EP0 338 151 A1 Decolonization of glycosides This patent deals with the decolorization of the average polysaccharide chain length exceeds glycosides which are useful as surfactants and for about 20. United States Patent 4,393,203 to Leslie other purposes. issued July 12, 1983 describes the treatment of Glycosides are known to have several uses glycosides with a wipe film evaporator to assist in including their incorporation into detergent products 5 color reduction. Rau in United States Patent as nonionic surfactants. Lower glycosides, that is 4,465,828 issued August 14, 1984 suggests using those materials having a short hydrophobic moiety hydroxy carboxylic acids to minimize color forma- attached to the saccharide backbone as later de- tion when preparing glycosides. -
Glycosylation of Caffeic Acid and Structural Analogues Catalyzed by Novel Glucansucrases from Leuconostoc and Weissella Species
Biocatalysis and Agricultural Biotechnology 19 (2019) 101114 Contents lists available at ScienceDirect Biocatalysis and Agricultural Biotechnology journal homepage: www.elsevier.com/locate/bab Glycosylation of caffeic acid and structural analogues catalyzed by novel T glucansucrases from Leuconostoc and Weissella species ∗ Johannes Nolte, Alexander Kempa, Arne Schlockermann, Matthias Hochgürtel, Ulrich Schörken Faculty of Applied Natural Sciences, TH Köln-Campus Leverkusen, Chempark Leverkusen E39, Kaiser-Wilhelm-Allee, 51368, Leverkusen, Germany ARTICLE INFO ABSTRACT Keywords: Twelve Leuconostoc and seven Weissella strains with extracellular glucansucrase activity were obtained from an Caffeic acid analysis of 41 lactic acid bacteria. Culture supernatants of all glucansucrase positive strains catalyzed the gly- Glucansucrase cosylation of caffeic acid with sucrose as donor substrate. Eighteen enzymes produced one major peak, which Leuconostoc was identified as caffeic acid-4′-O-α-D-monoglucoside by LC-MS and NMR spectroscopy. Only W. beninensis DSM Weissella 22752 formed significant amounts of the corresponding 3´-O-α-D-monoglucoside. The Weissella strain and five Acceptor reaction Leuconostoc strains with high glycosylation activity were selected for further studies. All glucansucrases cata- Transglycosylation lyzed the glycosylation of the catechol protocatechuic acid, a side-chain truncated analogue of caffeic acid. The Leuconostoc enzymes displayed a preference for the 4′-O-α-D isomer, while the DSM 22752 glucansucrase also produced the protocatechuic acid-3′-O-α-D-monoglucoside. Lower activities with non-catecholic caffeic acid derivatives and no activity with mono-methylated caffeic acid were observed with all glucansucrases. Time- course analyses confirmed that glucansucrase from L. citreum DSM 5577 was the most efficient biocatalyst for catechol glucosylation with yields of up to 74% caffeic acid glucosides after 24 h. -
Cosmetic Composition Containing Polyorganosiloxane-Containing Epsilon-Polylysine Polymer, and Polyhydric Alcohol, and Production Thereof
Europäisches Patentamt *EP001604647A1* (19) European Patent Office Office européen des brevets (11) EP 1 604 647 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: A61K 7/48, A61K 7/06, 14.12.2005 Bulletin 2005/50 A61K 7/02, C08G 81/00, C08G 77/452, C08G 77/455, (21) Application number: 05010234.2 C08L 83/10 (22) Date of filing: 11.05.2005 (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • Kawasaki, Yuji HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR Ibi-gun Gifu 501-0521 (JP) Designated Extension States: • Hori, Michimasa AL BA HR LV MK YU Gifu-shi Gifu 500-8286 (JP) • Yamamoto, Yuichi (30) Priority: 12.05.2004 JP 2004141778 5-1 Goikaigan Ichiharashi Chiba 290-8551 (JP) • Hiraki, Jun (71) Applicants: Tokyo 104-8555 (JP) • Ichimaru Pharcos Co., Ltd. Motosu-shi, Gifu 501-0475 (JP) (74) Representative: HOFFMANN EITLE • Chisso Corporation Patent- und Rechtsanwälte Osaka-shi, Osaka-fu 530-0005 (JP) Arabellastrasse 4 81925 München (DE) (54) Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof (57) It has been desired to develop a highly preserv- by reducing the amount of antibacterial preservative ative and antibacterial cosmetic composition that can agent to be used. easily be applied to both emulsion and non-emulsion There is provided a cosmetic composition compris- type cosmetics. It has also been desired to develop a ing one or a combination of two or more of polyorganosi- method of improving a preservative and/or antibacterial loxane-containing epsilon-polylysine compounds ob- effect(s) of a cosmetic composition comprising polyor- tained by reacting epsilon-polylysine with polyorganosi- ganosiloxane-containing epsilon-polylysine and there- loxane or a physiologically acceptable salt thereof, and polyhydric alcohol. -
United States Patent [19] [11] Patent Number: 5,641,480 Vermeer [45] Date of Patent: Jun
US005641480A United States Patent [19] [11] Patent Number: 5,641,480 Vermeer [45] Date of Patent: Jun. 24, 1997 [54] HAIR CARE COMPOSITIONS COMPRISING A New Family of Liquid Crystals: N-Substituted Aldona HETEROATOM CONTAINING ALKYL mides, Mol. Cryst. Liq. Cryst. 1986, vol. 135, pp. 93-110. ALDONAMIDE COMPOUNDS Molecular Packing and Hydrogen Bonding in the Crystal Structures of the N-(n-AlkyD-D-gluconarnide and the [75] Inventor: Robert Vermeer, Nutley, NJ. 1-Deoxy-(N-methyl-alkanamido)-D-glucitol Mesogens, Mol. Cryst. Liq. Cryst. 1990, vol. 185, PP - 209-213. [73] Assignee: Lever Brothers Company, Division of Conopco, Inc., New York, N.Y. Molecular Crystals and Liquid Crystals, vol. 198 (1991). Amphiphilic Properties of Synthetic Glycolipids Based on Amide Linkages, Zabel et al., Chemistry and Physics of [21] Appl. No.: 352,309 Lipids, 39 (1986) 313-327. [22] Filed: Dec. 8, 1994 Liquid-crystalline Behaviour in the N-alkyl Gluconamides and Other Related Carbohydrates, Pfanhemuller, Liquid [51] Int. (:1.6 ............................ .. A61K 7/07; A61K 7/075 Crystals, 1986, vol. 1, vol. 1, No. 4, 357-370. [52] US. Cl. ...................................... .. 424/7024; 424/701 Amphiphilic Properties of Synthetic Glycolipids Based in [58] Field of Search .............................. .. 424/701, 70.13, Amide Linkages, Makromol, Chem. 189, 2433-2442 424/7017, 70.24 (1988). [56] References Cited Molecular and Crystal Structures of N-(n-Heptyl)-and N-(n-DeCyD-D-GlycOnamide. Fahrnow et al., Carbohy U.S. PATENT DOCUMENTS drate Research 176 (1988) 165-174). 2,662,073 12/1953 Mehltretter et a1. ................. .. 536/172 Supramolecular Assemblies of Diacetylenic Aldonarnids, 2,721,211 10/1955 Frankel et al., J. -
~ Gerald Alan Lancaster 1968 Table of Contents
Conversion of Coumarin to MaliloUc Acid b;r ~es Isolated fram EBeudomonas Mac 291 by Gerald Alan Lancaster, B. A. (Hm.) A thesis submitted to the Facult,y of Graduate Studieô and Research in partial ful:filment 01' the requirements for the degree of Master 01' Science. Department of Micrabiology, Macdonald College of McGill University, P.Q.. June, 1967 ~ Gerald Alan Lancaster 1968 Table of Contents Page Introduction 1 Literature Review- Biological transformations of coumarin Bigher Plants 2 Animals 6 Fungi 8 Bacteria 9 MELterials and Methode Organism 13 Source of chemicals 13 Growth of cella 13 Chromatograph;y 14 Enzyme aas~ 15 Determina. tion of protein 15 Purification of the reductase 15 Resulta Detection of enzyme activit,y 16 Ass~ for the reductase 19 Ass~ for the hydrolase 19 Purification of the reductase 19 Properties of ooumarin oxidoreductase 29 Disoussion 40 Summary 42 Bibliograph;y 43 ....-.., . @.... ,.. Aolalowledgements The author expresses his sincere thanks to Dr. A. C. Blackwood for his help and his encouragement throughout the study. Thanks are also due to the various other graduate students in the Department of Microbiology- notably Mr. Y. D. Ha.ng and Mr-. P.C. Chang for encouragement and rewarding discussions on research. Financial assistance from the MCConnell Memorial Fellowship Fun~ 18 gratefully acknowledged. lIlarobSolosr ConnnioD of ~ 1io 118111otl0 .&oid li' BD. IaolaW tJoII JlaeudcllODU Rao 291 eDriohed l184ia. nclucea ooumann to d~l"OOO1JIIIlrlD ,. a Yeq epecUlo JaD&OÙ40ftdi1Otaae "Moh hae 1Hteft parified .8YeftteeDottcl~ ueing JlFAF-oellulo.. ohzoœatograpJv end caloium phosphate sel at tte pH DtabiliV optlmlll of pB 6.0. -
An Isolated Phytomolecule
Medical Botany 5: Active compounds in plants- cont. Alkaloids • • Nitrogenous bases which are found in plants and which are commonly found in plants and which can form salts with acids. • They are present as primary, secondary, tertiary, quaternary ammonium hydrates. • Alkaloid name is given because of similarity of alkalinity. • It is usually found in plants at 0.1-10%. O In the context of an alkaloid-bearing plant, the term usually means> 0.01% alkaloid. • Alkaloid morphine first isolated from the environment (Derosne and Seguin 1803-1804, Serturner 1805) O First synthesized cone (Ladenburg 1886) O The first used striknin (Magendie 1821) • Plants often have multiple alkaloids in different amounts in similar structures. • An alkaloide can be found in more than one plant family, as well as a single plant species. • Alkaloids are usually found in plants in their own water, in the form of their salts (salts with acids such as malic acid, tartaric acid, oxalic acid, tannic acid, citric acid). • They are found in almost all parts of plants (root, crust, leaf, seed etc.) but in different amounts. This does not mean that an alkaloid will be found in all parts of a plant. Some fruits only fruit (morphine, etc., while there are poppy seeds, not in the seed), Some of them are found in leaves and flowers (not found in the seeds of nicotine tobacco plant). • Nicotine, cones, other than those without oxygen in the constructions are usually white, crystallized dust; The above two substances are liquid. • Alkaloids are almost insoluble in water as free base (atropine, morphine); Some effects of alkaloids • Alkaloids have a wide variety of effects; Some alkaloids for some effects are as follows. -
Ep 3763419 A1
(19) *EP003763419A1* (11) EP 3 763 419 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 13.01.2021 Bulletin 2021/02 A61P 3/10 (2006.01) A61K 31/155 (2006.01) A61P 9/00 (2006.01) (21) Application number: 20191580.8 (22) Date of filing: 06.01.2012 (84) Designated Contracting States: • JONES, Christopher R. G. AL AT BE BG CH CY CZ DE DK EE ES FI FR GB San Diego, ca California 92129 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • BEELEY, Nigel R. A. PL PT RO RS SE SI SK SM TR Solana Beach, ca California 92075 (US) • FINEMAN, Mark S. (30) Priority: 07.01.2011 US 201161430914 P San Diego, CA California 92130 (US) (62) Document number(s) of the earlier application(s) in (74) Representative: Oetke, Cornelia accordance with Art. 76 EPC: Wallinger Ricker Schlotter Tostmann 12732408.5 / 2 661 266 Patent- und Rechtsanwälte Partnerschaft mbB Zweibrückenstraße 5-7 (71) Applicant: Anji Pharma (US) LLC 80331 München (DE) Boxford, MA 01921 (US) Remarks: (72) Inventors: This application was filed on 18-08-2020 as a • BARON, Alain D. divisional application to the application mentioned San Diego, ca California 92130 (US) under INID code 62. • BROWN, Martin R. Coronado, ca California 92118 (US) (54) CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES (57) Provided herein are methods for treating condi- tions associated with a chemosensory receptor, includ- ing diabetes, obesity, and other metabolic diseases, dis- orders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. -
Handbook of Herbs and Spices
Handbook of herbs and spices Volume 2 Edited by K. V. Peter CRC Press Boca Raton Boston New York Washington, DC Cambridge England Published by Woodhead Publishing Limited, Abington Hall, Abington Cambridge CB1 6AH, England www.woodhead-publishing.com Published in North America by CRC Press LLC, 2000 Corporate Blvd, NW Boca Raton FL 33431, USA First published 2004, Woodhead Publishing Ltd and CRC Press LLC © 2004, Woodhead Publishing Ltd The authors have asserted their moral rights. This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. Reasonable efforts have been made to publish reliable data and information, but the authors and the publishers cannot assume responsibility for the validity of all materials. Neither the authors nor the publishers, nor anyone else associated with the publication, shall be liable for any loss, damage or liability directly or indirectly caused or alleged to be caused by this book. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming and recording, or by any information storage or retrieval system, without permission in writing from the publishers. The consent of Woodhead Publishing and CRC Press does not extend to copying for general distribution, for promotion, for creating new works, or for resale. Specific permission must be obtained in writing from Woodhead Publishing or CRC Press for such copying. Trademark notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. -
Ep 1 602 354 B1
(19) & (11) EP 1 602 354 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 8/88 (2006.01) A61Q 5/00 (2006.01) 05.11.2008 Bulletin 2008/45 (86) International application number: (21) Application number: 04716754.9 PCT/JP2004/002606 (22) Date of filing: 03.03.2004 (87) International publication number: WO 2004/080433 (23.09.2004 Gazette 2004/39) (54) Use of polyglutamic acid or its salts Verwendung von Polyglutamatsäure oder deren Salze Utilisation de l’acide polyglutamique ou ses sels. (84) Designated Contracting States: • YAMADA, Kikumi, AT BE BG CH CY CZ DE DK EE ES FI FR GB GR c/o Ichimaru Pharcos Co., Ltd. HU IE IT LI LU MC NL PL PT RO SE SI SK TR Motosu-shi, Gifu 501-0475 (JP) (30) Priority: 10.03.2003 JP 2003062688 (74) Representative: Gille Hrabal Struck Neidlein Prop Roos (43) Date of publication of application: Patentanwälte 07.12.2005 Bulletin 2005/49 Brucknerstrasse 20 40593 Düsseldorf (DE) (73) Proprietor: Meiji Seika Kaisha Ltd. Chuo-ku, (56) References cited: Tokyo 104-8002 (JP) EP-A- 0 774 247 WO-A1-20/04039339 JP-A- 1 146 986 JP-A- 8 291 036 (72) Inventors: JP-A- 10 298 037 JP-A- 10 298 042 • HASEBE, Kohei, JP-A- 11 240 827 JP-A- 59 209 635 c/o Ichimaru Pharcos Co., Ltd. JP-A- 2001 354 542 JP-A- 2002 145 723 Motosu-shi, Gifu 501-0475 (JP) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations.